Creative Medical Technology (NASDAQ:CELZ – Get Free Report) is anticipated to release its resultson Friday, November 6th. Analysts expect the company to announce earnings of ($0.24) per share for the quarter.
Creative Medical Technology (NASDAQ:CELZ – Get Free Report) last announced its earnings results on Friday, August 7th. The company reported ($0.41) EPS for the quarter, missing the consensus estimate of ($0.39) by ($0.02). On average, analysts expect Creative Medical Technology to post ($1.18) EPS for the current fiscal year and ($0.88) EPS for the next fiscal year.
Creative Medical Technology Trading Down 5.8%
NASDAQ:CELZ opened at $0.68 on Friday. Creative Medical Technology has a 1-year low of $0.62 and a 1-year high of $4.72. The stock has a fifty day simple moving average of $0.94 and a 200 day simple moving average of $1.58.
Wall Street Analysts Forecast Growth
View Our Latest Stock Analysis on Creative Medical Technology
About Creative Medical Technology
Creative Medical Technology Holdings, Inc is a biotechnology company focused on developing regenerative medicine and cellular therapies. Its research programs are designed to use stem cells and other biological approaches to address conditions for which existing treatment options may be limited.
The company has developed and investigated therapies based on autologous stem cells, meaning cells collected from and administered back to the same patient. Its programs have included CaverStem, a regenerative treatment candidate for erectile dysfunction, as well as investigational platforms such as FemCelz for female sexual dysfunction and ImmCelz, an immune-modulating cellular therapy platform.
Further Reading
- Five stocks we like better than Creative Medical Technology
- Phillips 66 Posts Strong Earnings But the Stock Doesn’t Care
- NXP Semiconductors Falls After Strong Earnings—Is the Sell-Off Overdone?
- GE Vernova’s Reservations Are Turning Into Real Orders—But the Market Still Wants More.
- Where’s the Beef? Trian-Led Buyout Proposal Values Wendy’s at $1.4B, But Is It Enough?
Receive News & Ratings for Creative Medical Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Creative Medical Technology and related companies with MarketBeat.com's FREE daily email newsletter.
